Aldeyra Therapeutics, Inc.
جودة البيانات: 83%
ALDX
NASDAQ
Manufacturing
Chemicals
KWD 1.79
▼
KWD 0.01
(-0.28%)
6 months return
—
Momentum
Neutral
ROE
-64.76%
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-64.76%
أقل من متوسط القطاع (-54.47%)
ROIC-53.19%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
0.31
أعلى من متوسط القطاع (0.30)
Current Ratio2.72
Interest Coverage-18.51
التقييم
PE (TTM|NTM)
-2.80 | -6.91
أقل من متوسط القطاع (-1.50)
P/B Ratio1.92
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Debt/Equity of 0.31 — conservative balance sheet
Negative free cash flow of -33.35 M
Price History
الاتجاهات المالية
السعر المستهدف للمحللين
6 محللين
Buy
+320.2%
upside to target
الحالي
KWD 1.79
Consensus Target
KWD 7.50
KWD 2.00
أدنى
KWD 13.00
أعلى
التوقعات
مكرر الربحية المستقبلي
-6.91
ربحية السهم المستقبلية
-KWD 0.26
الإيرادات المقدّرة
29.13 M
مفاجآت الأرباح
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -KWD 0.12
·
Rev Est: 0.0
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | -KWD 0.17 | -KWD 0.16 | -KWD 0.13 | -KWD 0.10 | — | — |
| Estimate | -KWD 0.24 | -KWD 0.19 | -KWD 0.16 | -KWD 0.15 | -KWD 0.12 | -KWD 0.13 |
| المفاجأة | +30.33% | +14.67% | +17.46% | +31.03% | — | — |
Growth
Rev 5Y: N/A · Earnings 1Y: N/A
Growth
Rev 5Y: N/A · Earnings 1Y: N/A| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
Profitability
ROE: -64.76% · Net Margin: N/A
Profitability
ROE: -64.76% · Net Margin: N/A| Revenue (TTM) | N/A | Net Income (TTM) | -33.85 M |
| ROE | -64.76% | ROA | -41.59% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -33.35 M |
| ROIC | -53.19% | FCF Growth (3Y) | N/A |
Safety
D/E: 0.31 · Current: 2.72
Safety
D/E: 0.31 · Current: 2.72| Debt / Equity | 0.31 | Current Ratio | 2.72 |
| Interest Coverage | -18.51 | Asset Turnover | N/A |
| Working Capital | 48.98 M | Tangible Book Value | 49.24 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -2.80 · EV/EBITDA: N/A
Valuation
P/E: -2.80 · EV/EBITDA: N/A| P/E Ratio | -2.80 | Forward P/E | -6.91 |
| P/B Ratio | 1.92 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 3.25 | Fwd Earnings Yield | N/A |
| FCF Yield | -35.18% | ||
| Market Cap | 94.79 M | Enterprise Value | 50.75 M |
Per Share
EPS: -0.56 · FCF/Share: -0.55
Per Share
EPS: -0.56 · FCF/Share: -0.55| EPS (Diluted TTM) | -0.56 | Revenue / Share | N/A |
| FCF / Share | -0.55 | OCF / Share | -0.55 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 98.52% · CapEx/Rev: N/A
Efficiency
FCF Conv: 98.52% · CapEx/Rev: N/A| CapEx / Revenue | N/A | FCF Conversion | 98.52% |
| SBC-Adj. FCF | -41.57 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -33.85 M | -55.85 M | -37.54 M | -62.02 M | -57.78 M |
| EPS (Diluted) | -0.56 | -0.94 | -0.64 | -1.06 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -35.27 M | -60.12 M | -42.79 M | -62.68 M | -56.22 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 25.66 M | 48.22 M | 29.46 M | 47.31 M | 44.94 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 1.91 M | 1.93 M | 2.07 M | 1.69 M | 1.74 M |
| Income Tax | 0.0 | 1,000.0 | 0.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 72.06 M | 104.61 M | 148.33 M | 181.29 M | 233.14 M |
| Total Liabilities | 27.81 M | 33.60 M | 28.53 M | 30.28 M | 27.40 M |
| Shareholders' Equity | 44.25 M | 71.00 M | 119.80 M | 151.01 M | 205.74 M |
| Total Debt | 15.30 M | 15.30 M | 15.29 M | 16.34 M | 16.04 M |
| Cash & Equivalents | 70.04 M | 54.53 M | 144.42 M | 144.42 M | 229.79 M |
| Current Assets | 71.78 M | 104.07 M | 147.81 M | 181.02 M | 232.75 M |
| Current Liabilities | 27.81 M | 18.60 M | 22.26 M | 15.36 M | 11.77 M |
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1605 نظير)
مقارنة بشركات مشابهة في Manufacturing
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1605 نظير) مقارنة بشركات مشابهة في Manufacturing| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -2.8 | -1.5 |
| P/B | 1.9 | 1.6 |
| ROE % | -64.8 | -54.5 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.7 |
| D/E | 0.3 | 0.3 |
{"event":"ticker_viewed","properties":{"ticker":"ALDX","listing_kind":"stock","pathname":"/stocks/aldx","exchange":"NASDAQ","country":"US"}}